» Articles » PMID: 9557757

Identification of Hepatitis G Virus Particles in Human Serum by E2-specific Monoclonal Antibodies Generated by DNA Immunization

Overview
Journal J Virol
Date 1998 Apr 29
PMID 9557757
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

In order to elucidate the structure and morphology of hepatitis G virus (HGV), a recently isolated flavivirus, we generated a panel of eight monoclonal antibodies (MAbs) against the putative second envelope protein (E2) following DNA immunization. The MAbs were shown to be specific for four different epitopes on recombinant E2. MAb Mc6 was the only antibody able to detect the linear epitope LTGGFYEPL. In addition, Mc6 was able to immunoprecipitate viral particles in human blood samples as detected by reverse transcription-PCR amplification of HGV RNA. This precipitation could be competed by addition of saturating amounts of the linear peptide or abolished by addition of Nonidet P-40. We conclude that, albeit lacking the N-terminal sequence of a functional core protein, HGV builds classical viral particles displaying E2 envelope protein on their outer surfaces.

Citing Articles

Human Pegivirus Type 1: A Common Human Virus That Is Beneficial in Immune-Mediated Disease?.

Stapleton J Front Immunol. 2022; 13:887760.

PMID: 35707535 PMC: 9190258. DOI: 10.3389/fimmu.2022.887760.


DNA immunization as a technology platform for monoclonal antibody induction.

Liu S, Wang S, Lu S Emerg Microbes Infect. 2016; 5:e33.

PMID: 27048742 PMC: 4855071. DOI: 10.1038/emi.2016.27.


GB virus type C envelope protein E2 elicits antibodies that react with a cellular antigen on HIV-1 particles and neutralize diverse HIV-1 isolates.

Mohr E, Xiang J, McLinden J, Kaufman T, Chang Q, Montefiori D J Immunol. 2010; 185(7):4496-505.

PMID: 20826757 PMC: 3544363. DOI: 10.4049/jimmunol.1001980.


GB virus type C interactions with HIV: the role of envelope glycoproteins.

Mohr E, Stapleton J J Viral Hepat. 2009; 16(11):757-68.

PMID: 19758271 PMC: 3543829. DOI: 10.1111/j.1365-2893.2009.01194.x.


Characterization of an immunodominant antigenic site on GB virus C glycoprotein E2 that is involved in cell binding.

McLinden J, Kaufman T, Xiang J, Chang Q, Klinzman D, Engel A J Virol. 2006; 80(24):12131-40.

PMID: 17035329 PMC: 1676310. DOI: 10.1128/JVI.01206-06.


References
1.
Hijikata M, Shimizu Y, Kato H, Iwamoto A, Shih J, Alter H . Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes. J Virol. 1993; 67(4):1953-8. PMC: 240263. DOI: 10.1128/JVI.67.4.1953-1958.1993. View

2.
THOMSSEN R, Bonk S, Propfe C, Heermann K, Kochel H, Uy A . Association of hepatitis C virus in human sera with beta-lipoprotein. Med Microbiol Immunol. 1992; 181(5):293-300. DOI: 10.1007/BF00198849. View

3.
Kanto T, Hayashi N, Takehara T, Hagiwara H, Mita E, Naito M . Buoyant density of hepatitis C virus recovered from infected hosts: two different features in sucrose equilibrium density-gradient centrifugation related to degree of liver inflammation. Hepatology. 1994; 19(2):296-302. View

4.
Shindo M, Di Bisceglie A, Akatsuka T, Fong T, Scaglione L, Donets M . The physical state of the negative strand of hepatitis C virus RNA in serum of patients with chronic hepatitis C. Proc Natl Acad Sci U S A. 1994; 91(18):8719-23. PMC: 44678. DOI: 10.1073/pnas.91.18.8719. View

5.
Linnen J, Wages Jr J, FRY K, Krawczynski K, Alter H, Koonin E . Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science. 1996; 271(5248):505-8. DOI: 10.1126/science.271.5248.505. View